BioFlyte Raises $5.4M in Series B Financing to Protect Critical Infrastructure from Airborne Biothreats

The product solution combines HP’s new D100 Single Cell Dispenser with BioSkryb’s ResolveDNA® technology to enable the investigation of large single-cell genomics studies with unprecedented coverage and accuracy